Gables Capital Management Inc. Trevena Inc Transaction History

Gables Capital Management Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Oct 30, 2019	SELL	$0.81 - $1.06 $81 - $106	-100 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$1.39 - $2.25 $139 - $225	100 New	100 $0

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Gables Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Gables Capital Management Inc. with notifications on news.